Literature DB >> 8709707

Riluzole and amyotrophic lateral sclerosis.

R J Guiloff, A Goonetilleke, J Emami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8709707     DOI： 10.1016/s0140-6736(05)64505-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Cost-benefit analysis of riluzole for the treatment of amyotrophic lateral sclerosis.

Authors:  G M Ginsberg; B Lev
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

Review 2.  Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.

Authors:  Gary Ginsberg; Serena Lowe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.